Researchers at National Jewish Health have identified an immune and lipid profile on the surface of the skin of infants that can predict the development of atopic dermatitis, or eczema, months before the onset of clinical illness. Atopic dermatitis affects 20-30% of children worldwide. Atopic dermatitis commonly occurs in children and can progress into what is called the atopic or allergic march, which refers to the progression of diseases that often begin early in life. Once the skin rash occurs, food allergies, asthma, and other problems can develop.
Researchers discover biomarkers that could predict future allergic conditions
Researchers at National Jewish Health have identified an immune and lipid profile on the surface of the skin of infants that can predict the development of atopic dermatitis, or eczema, months before the onset of clinical illness. Atopic dermatitis affects 20-30% of children worldwide. Atopic dermatitis commonly occurs in children and can progress into what is called the atopic or allergic march, which refers to the progression of diseases that often begin early in life. Once the skin rash occurs, food allergies, asthma, and other problems can develop.